Aliskiren Evaluation on Left Ventricular Diastolic Dysfunction.
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2013
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension; Left ventricular dysfunction
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms ALEDY
- 25 Apr 2013 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 01 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Jun 2011 New trial record